<div id="readability-page-1"><div><p>[WASHINGTON] The US Department of Justice (DOJ) is probing market volatility at a Hong-Kong based traditional Chinese medicine company after a stock surge briefly made its value soar 46,000 per cent.</p><p>The DOJ sent a subpoena to Regencell Bioscience to turn over documents and communications concerning trading in the company’s shares “and other corporate operational, financial and accounting matters”, according to the company’s financial report filed with the US Securities and Exchange Commission on Friday (Oct 31) in Washington.</p><p>“We are cooperating with this investigation, but we cannot predict its ultimate resolution,” the filing states. Company representatives didn’t immediately respond to a request for comment sent after business hours on Friday. A spokesperson for DOJ also didn’t immediately respond to a request for comment.</p><p>Regencell made headlines in June when its stock price soared despite no apparent news from the company, which markets and licenses traditional treatments for ADHD and autism spectrum disorder. The rally briefly vaulted its chief executive officer’s net worth to among the world’s largest fortunes.</p><p>The firm, which debuted on the Nasdaq Capital Market in 2021, is in the research and development stage and has not generated any revenue in any years since, according to its filing.</p><p>“We have no saleable products and have not generated any revenue from product sales,” it states.</p><p>The company addressed the volatility in its securities filing. “We believe this volatility may be caused in substantial part by a ‘short squeeze’ or other anomalous trading activity causing demand for, and price of, our ordinary shares to increase,” it said. BLOOMBERG</p></div></div>

脑再生科技

<p>美国司法部正在调查总部位于香港的传统中医药公司脑再生科技，该公司的股票上涨了 46,000%。司法部已发出传票，要求提供与交易和公司事务相关的文件。脑再生科技自 2021 年在纳斯达克上市以来未产生收入，认为股价波动可能与潜在的空头挤压或异常交易活动有关。该公司正在配合调查，但无法预测调查结果</p>

美国司法部正在调查一家股价飙升 46,000% 的草药公司的交易活动